Inhibition of the proliferation of human liver cancer cell line (HepG2) and human hepatocarcinoma cell line (SMMC-7721) and induction apoptosis, concomitant with the down-regulation of survivin (paeonol). Here, BIRC5 is linked to liver cancer.